Yongjian Wu

Effect of chemotherapy in tumor on coronary arteries: Mechanisms and management

Chengqing Jiang, Haiyan Xu, Yongjian Wu, 2023, Life Sciences.

Early 6 months usage of single anTiplAtelet OR anTicoAgulant followed by single antiplatelet after transcatheter aortic valve replacement: protocol for a multicentre, open-label, randomised controlled clinical trial

Y. Ye, Mo-yang Wang, G. Niu, 2023, BMJ open.

Contemporary spectrum, characteristics, and outcomes of adult patients with rheumatic valvular disease in China: Insights from the China-VHD study

Y. Ye, Haitong Zhang, Bin Zhang, 2024, International journal of cardiology. Cardiovascular risk and prevention.

Clinical Characteristics, Outcomes, and Risk Stratification of Combined Mitral and Tricuspid Regurgitation

Y. Ye, Haitong Zhang, Bin Zhang, 2024, JACC: Asia.

Prevalence and impact of diabetes in patients with valvular heart disease

Y. Ye, Haitong Zhang, Bin Zhang, 2024, iScience.